Erythema nodosum--diagnostic difficulties in the accident and emergency department.

New cases of thalidomide embryopathy in Brazil.

Thalidomide is the best known human teratogen. Although withdrawn from the market in 1961, thalidomide was remarketed after 1965 in several countries, for the treatment of erythema nodosum leprosum. Thalidomide has a potent immunomodulatory property and has now a number of approved and off-label uses in dermatologic, oncologic, infectious and gastrointestinal conditions. In the U.S., FDA approv...

Granulomatous lobular mastitis as a rare cause of Erythema Nodosum: Report of two cases

Granulomatous lobular mastitis (GLM) is a rare and benign condition of unknown etiology, which has been described recently. It primary affects young parous women and usually presents with a unilateral and extra-areolar breast mass. The condition may clinically mimic breast cancer, sometimes leading to misdiagnosis resulting in unnecessary breast surgery.We report two ca...

Concurrent Sweet’s syndrome and erythema nodosum: two manifestations of the same disease or the same spectrum?

Sweet’s syndrome and erythema nodosum are rarely seen together. Herein, we report a case of concurrent Sweet’s syndrome and erythema nodosum and review previous cases.

Association of Methylmalonic Acidemia and Erythema Nodosum

Erythema nodosum :what should we consider about it?